Skip to main content

Ayvakit

Generic: avapritinib

Verified·Oct 26, 2026
Manufacturer
Blueprint
NDC
72064-110
RxCUI
2272112
Route
ORAL
ICD-10 indication
C49.A0

Affordability Check

How much will you actually pay for Ayvakit?

In 30 seconds, see every legitimate way to afford Ayvakit — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Ayvakit

What is this medication?

Ayvakit is a prescription medication primarily used to treat adults with two specific medical conditions. First, it is approved for the treatment of advanced systemic mastocytosis, which is a rare blood disorder caused by the buildup of mast cells in the body's organs. It is also used for indolent systemic mastocytosis in patients whose symptoms are not well-controlled by other treatments. By targeting the underlying cause of these conditions, the drug helps to reduce symptoms and the overall burden of the disease.

Additionally, Ayvakit is indicated for the treatment of adults with a specific type of stomach or intestinal cancer called gastrointestinal stromal tumor, or GIST. This application is specifically for tumors that cannot be removed by surgery or have spread to other parts of the body and possess a particular genetic change known as a PDGFRA exon 18 mutation. As a kinase inhibitor, the medication works by blocking certain proteins that signal cancer cells to grow and divide, thereby slowing the progression of the disease.

Copay & patient assistance

  • Patient Copay Amount: As little as $0
  • Maximum Annual Benefit Limit: $25,000
  • Core Eligibility Restrictions: Patients must have commercial insurance (provided through an employer or purchased independently); must be a U.S. resident aged 18 or older; requires enrollment by a healthcare provider and patient consent/authorization.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How Ayvakit appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

49%

2,702 of 5,499 plans

Most common tier

Tier 5

On 78% of covering formularies

Prior authorization required

100%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)40
19%
Tier 2 (generic)1
0%
Tier 4 (non-preferred brand)4
2%
Tier 5 (specialty)163
78%

Step therapy: 0% of formularies

Quantity limits: 97% of formularies

Coverage breadth: 208 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

Ayvakit treats 2 rare conditions. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.